Bo‐Tao Xin

630 total citations
20 papers, 492 citations indexed

About

Bo‐Tao Xin is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Bo‐Tao Xin has authored 20 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Bo‐Tao Xin's work include Ubiquitin and proteasome pathways (12 papers), Peptidase Inhibition and Analysis (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Bo‐Tao Xin is often cited by papers focused on Ubiquitin and proteasome pathways (12 papers), Peptidase Inhibition and Analysis (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Bo‐Tao Xin collaborates with scholars based in Netherlands, Germany and Switzerland. Bo‐Tao Xin's co-authors include Herman S. Overkleeft, Gerjan de Bruin, Christoph Driessen, Bogdan I. Florea, E.M. Huber, M. Groll, Alexei F. Kisselev, Huib Ovaa, Elmer Maurits and Paul P. Geurink and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Bo‐Tao Xin

19 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo‐Tao Xin Netherlands 13 395 159 145 56 49 20 492
Göran Dahl Sweden 14 462 1.2× 147 0.9× 78 0.5× 48 0.9× 50 1.0× 22 677
Nilesh Zaware United States 12 463 1.2× 102 0.6× 141 1.0× 71 1.3× 24 0.5× 19 625
Zhihao Liu China 15 438 1.1× 131 0.8× 183 1.3× 53 0.9× 24 0.5× 54 688
Andrew B. Benowitz United States 13 509 1.3× 207 1.3× 187 1.3× 98 1.8× 21 0.4× 22 714
Joel Desharnais United States 11 508 1.3× 129 0.8× 205 1.4× 28 0.5× 30 0.6× 14 676
Steven DellaRocca United States 7 515 1.3× 177 1.1× 89 0.6× 39 0.7× 51 1.0× 12 629
Anna Lucia Fallacara Italy 17 299 0.8× 98 0.6× 230 1.6× 41 0.7× 47 1.0× 28 603
Emanuela Capota United States 6 571 1.4× 152 1.0× 91 0.6× 80 1.4× 43 0.9× 8 688
Lindsay Stimson United Kingdom 11 870 2.2× 216 1.4× 96 0.7× 55 1.0× 40 0.8× 13 1.0k
Nicolas Basse France 13 565 1.4× 259 1.6× 73 0.5× 63 1.1× 143 2.9× 18 775

Countries citing papers authored by Bo‐Tao Xin

Since Specialization
Citations

This map shows the geographic impact of Bo‐Tao Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Tao Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Tao Xin more than expected).

Fields of papers citing papers by Bo‐Tao Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo‐Tao Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Tao Xin. The network helps show where Bo‐Tao Xin may publish in the future.

Co-authorship network of co-authors of Bo‐Tao Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Bo‐Tao Xin. A scholar is included among the top collaborators of Bo‐Tao Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo‐Tao Xin. Bo‐Tao Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zacarı́as, Natalia V. Ortiz, Sascha Röth, Bo‐Tao Xin, et al.. (2025). Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular Degraders. Journal of Medicinal Chemistry. 68(24). 26525–26546.
2.
Kooij, Raymond, Ayşegül Sapmaz, Bo‐Tao Xin, et al.. (2020). Small-Molecule Activity-Based Probe for Monitoring Ubiquitin C-Terminal Hydrolase L1 (UCHL1) Activity in Live Cells and Zebrafish Embryos. Journal of the American Chemical Society. 142(39). 16825–16841. 54 indexed citations
3.
Xin, Bo‐Tao, E.M. Huber, Gerjan de Bruin, et al.. (2019). Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits. Journal of Medicinal Chemistry. 62(3). 1626–1642. 28 indexed citations
4.
Xin, Bo‐Tao, Gan Jin, Daniel J. Fernandez, et al.. (2019). Total chemical synthesis of murine ISG15 and an activity-based probe with physiological binding properties. Organic & Biomolecular Chemistry. 17(48). 10148–10152. 12 indexed citations
5.
Bešše, Andrej, Lenka Bešše, Marianne Kraus, et al.. (2019). Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors. Cell chemical biology. 26(3). 340–351.e3. 84 indexed citations
6.
Xin, Bo‐Tao, Gerjan de Bruin, Dmitri V. Filippov, et al.. (2019). Two‐Step Bioorthogonal Activity‐Based Protein Profiling of Individual Human Proteasome Catalytic Sites. ChemBioChem. 21(1-2). 248–255. 3 indexed citations
7.
Eising, Selma, et al.. (2018). Coordination‐Assisted Bioorthogonal Chemistry: Orthogonal Tetrazine Ligation with Vinylboronic Acid and a Strained Alkene. ChemBioChem. 19(15). 1648–1652. 16 indexed citations
8.
Xin, Bo‐Tao, et al.. (2018). Native chemical ligation at methionine bioisostere norleucine allows for N-terminal chemical protein ligation. Organic & Biomolecular Chemistry. 16(34). 6306–6315. 6 indexed citations
9.
Bhattarai, Salyan, Sabine Krause, Olivier Benvéniste, et al.. (2016). The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. Journal of Autoimmunity. 75. 118–129. 34 indexed citations
10.
Bruin, Gerjan de, Bo‐Tao Xin, Bogdan I. Florea, & Herman S. Overkleeft. (2016). Proteasome Subunit Selective Activity-Based Probes Report on Proteasome Core Particle Composition in a Native Polyacrylamide Gel Electrophoresis Fluorescence-Resonance Energy Transfer Assay. Journal of the American Chemical Society. 138(31). 9874–9880. 20 indexed citations
11.
Xin, Bo‐Tao, et al.. (2016). Incorporation of the Constrained Peptidomimetic, 5‐Methylpyridin‐2‐one into Peptide Vinyl Sulfones and Peptide Epoxy Ketones is Detrimental for Proteasome Inhibition. European Journal of Organic Chemistry. 2016(6). 1132–1144. 2 indexed citations
12.
Xin, Bo‐Tao, Yimeng Du, Bogdan I. Florea, et al.. (2016). Development of new Malt1 inhibitors and probes. Bioorganic & Medicinal Chemistry. 24(15). 3312–3329. 18 indexed citations
13.
Xin, Bo‐Tao, Gerjan de Bruin, E.M. Huber, et al.. (2016). Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes. Journal of Medicinal Chemistry. 59(15). 7177–7187. 19 indexed citations
14.
Jiao, Yu, Bo‐Tao Xin, Yanmin Zhang, et al.. (2014). Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents. European Journal of Medicinal Chemistry. 90. 170–183. 43 indexed citations
15.
Xin, Bo‐Tao, Gerjan de Bruin, Martijn Verdoes, et al.. (2014). Exploring dual electrophiles in peptide-based proteasome inhibitors: carbonyls and epoxides. Organic & Biomolecular Chemistry. 12(30). 5710–5718. 6 indexed citations
16.
Bruin, Gerjan de, E.M. Huber, Bo‐Tao Xin, et al.. (2014). Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes. Journal of Medicinal Chemistry. 57(14). 6197–6209. 86 indexed citations
17.
Xin, Bo‐Tao, Weifang Tang, Yue Wang, et al.. (2012). Design, synthesis and biological evaluation of β-carboline derivatives as novel inhibitors targeting B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 22(14). 4783–4786. 30 indexed citations
18.
Xin, Bo‐Tao, Qingfa Zhou, & Tao Lu. (2012). Recent Development in Aerobic Oxidation of Amines. Mini-Reviews in Organic Chemistry. 9(3). 319–340. 1 indexed citations
19.
Xin, Bo‐Tao, Qingfa Zhou, & Tao Lu. (2012). Recent Development in Aerobic Oxidation of Amines. Mini-Reviews in Organic Chemistry. 9(3). 319–340. 4 indexed citations
20.
Li, Huifang, Tao Lu, Tian Zhu, et al.. (2008). Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas. European Journal of Medicinal Chemistry. 44(3). 1240–1249. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Göran Dahl Breakdown of academic impact, for papers by Nilesh Zaware Breakdown of academic impact, for papers by Zhihao Liu Breakdown of academic impact, for papers by Andrew B. Benowitz Breakdown of academic impact, for papers by Joel Desharnais Breakdown of academic impact, for papers by Steven DellaRocca Breakdown of academic impact, for papers by Anna Lucia Fallacara Breakdown of academic impact, for papers by Emanuela Capota Breakdown of academic impact, for papers by Lindsay Stimson Breakdown of academic impact, for papers by Nicolas Basse
Rankless by CCL
2026